undefined
CBC Group Visited Jiudian Hongyang Pharmaceutical
Release time:
2024-08-09 14:40
Source:
On August 7th, Kazuki Chihonmatsu, an expert from the Life Science Department of CBC Corporation in Tokyo, and Kenso Sarukin, a senior manager of the Agrochemical Division of Shanghai Pharmaceutical, visited JiuDian HongYang Pharmaceutical. Zeng Ling, Director of International Development Department of Jiudian Hongyang Pharmaceutical, Li Ning, Director of Quality Department, and Liu Junwen, Deputy Director of Production Department, participated in the reception.
CBC Corporation is a group of companies established since 1925 with both trading and manufacturing functions, and now has 50 branches in about 20 countries in the world, and in recent years, the trade business of pharmaceuticals and biopharmaceuticals and pesticides has developed rapidly.
The CBC team learned in details about the basic situation of Jiudian Hongyang Pharmaceutical, the types of APIs and excipients and GMP management, the production and sales of injectable excipients and the advantageous varieties, and visited the feeding and drying equipments, finished product warehouses and logistic platforms of the production workshop of bio-excipients, as well as introduced CBC's global sales network and the registered team in the Japanese market. Mr. Li introduced the design and capacity of the new bio-excipient workshop of Jiudian Hongyang Pharmaceutical, which will be put into operation early next year. Mrs. Zeng and the CBC team had in-depth exchanges on the future fitting projects and CDMO capacity of Jiudian.
The capacity upgrade brought by Jiudian Hongyang Pharmaceutical's injection-grade excipients items and the bio-excipients workshop to be put into production soon complemented well with the CBC team's customer resources, registration experience in the Japanese market and promotion experience in the global market. In the future, both parties will work closely together to help Jiudian Hongyang Pharmaceutical's products go to overseas regulated markets.
Related news